Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

480 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.
Krischer JP, Cuthbertson DD, Yu L, Orban T, Maclaren N, Jackson R, Winter WE, Schatz DA, Palmer JP, Eisenbarth GS. Krischer JP, et al. Among authors: eisenbarth gs. J Clin Endocrinol Metab. 2003 Jan;88(1):103-8. doi: 10.1210/jc.2002-020760. J Clin Endocrinol Metab. 2003. PMID: 12519837
The "natural" history of type I diabetes.
Eisenbarth GS, Connelly J, Soeldner JS. Eisenbarth GS, et al. Diabetes Metab Rev. 1987 Oct;3(4):873-91. doi: 10.1002/dmr.5610030404. Diabetes Metab Rev. 1987. PMID: 3315524 Review. No abstract available.
Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.
Yu L, Cuthbertson DD, Maclaren N, Jackson R, Palmer JP, Orban T, Eisenbarth GS, Krischer JP; DPT-1 Participating Investigators. Yu L, et al. Among authors: eisenbarth gs. Diabetes. 2001 Aug;50(8):1735-40. doi: 10.2337/diabetes.50.8.1735. Diabetes. 2001. PMID: 11473032
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS. Verge CF, et al. Among authors: eisenbarth gs. Diabetes. 1998 Dec;47(12):1857-66. doi: 10.2337/diabetes.47.12.1857. Diabetes. 1998. PMID: 9836516
Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.
Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS. Verge CF, et al. Among authors: eisenbarth gs. Diabetes. 1996 Jul;45(7):926-33. doi: 10.2337/diab.45.7.926. Diabetes. 1996. PMID: 8666144
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Gianani R, Pugliese A, Bonner-Weir S, Shiffrin AJ, Soeldner JS, Erlich H, Awdeh Z, Alper CA, Jackson RA, Eisenbarth GS. Gianani R, et al. Among authors: eisenbarth gs. Diabetes. 1992 Mar;41(3):347-53. doi: 10.2337/diab.41.3.347. Diabetes. 1992. PMID: 1551494
Insulin prophylaxis in individuals at high risk of type I diabetes.
Keller RJ, Eisenbarth GS, Jackson RA. Keller RJ, et al. Among authors: eisenbarth gs. Lancet. 1993 Apr 10;341(8850):927-8. doi: 10.1016/0140-6736(93)91215-8. Lancet. 1993. PMID: 8096268 Clinical Trial.
Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes.
Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth GS. Ziegler AG, et al. Among authors: eisenbarth gs. Diabetes. 1989 Oct;38(10):1320-5. doi: 10.2337/diab.38.10.1320. Diabetes. 1989. PMID: 2676660
First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion.
Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS. Srikanta S, et al. Among authors: eisenbarth gs. N Engl J Med. 1985 Aug 22;313(8):461-4. doi: 10.1056/NEJM198508223130801. N Engl J Med. 1985. PMID: 3894969
Diminished A-cell secretion in the early phase of type I diabetes mellitus.
Ganda OP, Srikanta S, Gleason RE, Soeldner JS, Eisenbarth GS. Ganda OP, et al. Among authors: eisenbarth gs. Metabolism. 1986 Nov;35(11):1074-7. doi: 10.1016/0026-0495(86)90046-6. Metabolism. 1986. PMID: 3534518
480 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback